3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Brain Neoplasms
2
Wilms Tumor
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neutropenia
1
Neurotoxicity Syndromes
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Interventions
Cyclophosphamide
17
Peripheral Blood Stem Cell Transplantation
16
fludarabine phosphate
15
Busulfan
15
Tacrolimus
13
Methotrexate
13
Mycophenolic Acid
11
Cyclosporine
11
Antilymphocyte Serum
11
Whole-Body Irradiation
9
Flow Cytometry
8
Radiotherapy
6
Methylprednisolone
6
Melphalan
6
Filgrastim
6
Etoposide
6
Cord Blood Stem Cell Transplantation
6
Therapeutics
5
Psychiatric Rehabilitation
5
Sirolimus
4
Polymerase Chain Reaction
4
Immunoenzyme Techniques
4
thymoglobulin
3
Rituximab
3
Ondansetron
3
Immunologic Techniques
3
Early Intervention, Educational
3
Cyclosporins
3
Aprepitant
3
Alemtuzumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pdgfra-Associated Chronic Eosinophilic Leukemia
×
Lithium Carbonate
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts